• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
All
Options & Futures
Funds
IPO Subscription
Structured Products
Investment Wiki
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List

Avidity Biosciences(RNA.US)

Overview
News
Financials
© 2026 Longbridge|Disclaimer

Event Tracking

Dec16
Pharmaceutical Industry M&A Value Up 31% in 2025 to $179.6 Billion
17:43
Nov24
Avidity Biosciences Inc. Special Shareholder Meeting to Vote on Novartis Merger Agreement
22:11
Nov19
Avidity Biosciences Announces Management Access Program for DMD Patients
14:14
Nov14
FactSet analysts lower 2025 EPS forecast for Avidity Biosciences Inc
12:22
Nov11
RBC Capital analyst reiterates hold rating on Avidity Biosciences
12:32
Avidity Biosciences released FY2025 9 Months Earnings on November 10 (EST), with actual revenue of USD 17.9 M and EPS of USD -3.3836
04:00

Schedules & Filings

Schedules
Filings
Nov10
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 12.48 M, Net Income -174.44 M, EPS -1.265

Aug7
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 3.847 M, Net Income -157.32 M, EPS -1.2136

May8
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 1.573 M, Net Income -115.77 M, EPS -0.9

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
INBS
9.530
+132.44%
+5.430
ANGH
3.770
+62.50%
+1.450
WTO
1.020
+61.09%
+0.387
ESHAR
0.2500
+47.06%
+0.080
NCL
0.2731
+40.77%
+0.079
FGMCR
0.5500
+33.50%
+0.138
ESHA
19.180
+33.38%
+4.800
IPEXR
0.8000
+31.97%
+0.194
RDACR
0.2400
+26.32%
+0.050
DVLT
0.6521
+26.25%
+0.136
View More